Department of Medicine and Surgery, University of Parma, Parma, Italy.
Unit of General Surgery, University Hospital of Parma, Parma, Italy.
Anticancer Res. 2024 Sep;44(9):3955-3964. doi: 10.21873/anticanres.17224.
BACKGROUND/AIM: The Controlling Nutritional status (CONUT) score, a valuable tool evaluating the preoperative conditions of patients from a nutritional point of view, has been successfully adopted for a plethora of malignancies including colorectal cancer (CRC). However, since rectal cancer has characteristics that differ from colon cancer (CC) and because, as of 2024, investigations targeted to surgical CC patients are lacking in the pertinent literature, we decided to assess the predictive role of this scoring system in relation to postoperative course and survival of surgical patients affected only by this malignancy. However, as of 2024, the existing literature on CONUT has typically treated colorectal cancer (CRC) as a single homogeneous entity, often combining results for both colon cancer (CC) and rectal cancer (RC). Since CC differs from RC in pathobiology, prognosis and treatment, we preferred to investigate CONUT in patients affected with CC in order to corroborate or refute the current knowledge on this score system when applied to CRC. With this stated aim, we proceeded to assess the predictive role of CONUT in relation to postoperative course and prognosis of patients who underwent CC surgery only.
We retrospectively analyzed data from 341 CC patients who underwent surgery at our Hospital between 2013 and 2018. Starting from serum measurements of lymphocytes, total cholesterol and albumin we used a simplified two-tier CONUT classification in order of increasing severity: high (score ≥3) and low score (scoring <3).
On equal staging class and other clinicopathological terms, compared to their high score counterpart, low CONUT subjects went through postoperative complications (both nonsurgical and surgical ones) less frequently, shorter mean hospital stay (11.2 versus 15 days) and more favorable survival (both overall and disease-free survival) with statistical significance.
In the light of our results, we encourage to systematically resort to the CONUT score classification in all CC patients scheduled for a curative surgery. Preoperative correction of CONUT parameters through artificial nutrition or other measures appears mandatory as it can drastically improve the postoperative course as well as the long-term prognosis of these subjects.
背景/目的:控制营养状况(CONUT)评分是一种从营养角度评估患者术前状况的有价值工具,已成功应用于多种恶性肿瘤,包括结直肠癌(CRC)。然而,由于直肠肿瘤具有不同于结肠癌(CC)的特征,并且截至 2024 年,相关文献中缺乏针对手术 CC 患者的调查,因此我们决定评估该评分系统在手术患者术后过程和生存中的预测作用,这些患者仅患有这种恶性肿瘤。然而,截至 2024 年,关于 CONUT 的现有文献通常将结直肠癌(CRC)视为单一的同质实体,通常将结肠癌(CC)和直肠肿瘤(RC)的结果结合在一起。由于 CC 在病理生物学、预后和治疗方面与 RC 不同,我们更愿意在患有 CC 的患者中研究 CONUT,以证实或反驳当前关于该评分系统应用于 CRC 的知识。基于这一目的,我们着手评估 CONUT 在仅接受 CC 手术的患者术后过程和预后方面的预测作用。
我们回顾性分析了 2013 年至 2018 年间在我院接受手术的 341 例 CC 患者的数据。从淋巴细胞、总胆固醇和白蛋白的血清测量值出发,我们使用简化的两层次 CONUT 分类,按严重程度递增:高(评分≥3)和低评分(评分<3)。
在相同分期类别和其他临床病理术语下,与高评分组相比,低 CONUT 组的患者术后并发症(包括非手术和手术并发症)发生率较低,平均住院时间较短(11.2 天对 15 天),生存情况更好(总生存和无病生存),差异具有统计学意义。
根据我们的结果,我们鼓励在所有计划接受根治性手术的 CC 患者中系统地采用 CONUT 评分分类。通过人工营养或其他措施纠正 CONUT 参数似乎是必要的,因为它可以极大地改善这些患者的术后过程和长期预后。